Genentech

PULMOZYME

Manufacturer:

Genentech

Pulmozyme HCPCS:

J7639

HCPCS Code Descriptor:

Dornase alfa, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram

Category:

J Code

Pulmozyme NDCs:

50242-0100-40

Primary Type:

Pulmonary

Generic/Specialty Status:

Single-Source

Route of Administration:

Inhalation

Potential NDC Listing Errors:

Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.

About Pulmozyme:

PULMOZYME is a Pulmonary drug manufactured by Genentech and administered via the Inhalation route of administration. The J Code: J7639 is aligned to the drug PULMOZYME.

ACCESS PRICING AND MORE BY REGISTERING

J7639 Added Date:

January 1, 2000

J7639 Effective Date:

January 1, 2009

J7639 Termination Date:

HCPCS Active

Pulmozyme billing and coding information can be found through Genentech at the link below:
Pulmozyme patient assistance information can be found through Genentech at the URL: https://www.gene.com/patients/patient-foundation
PULMOZYME prescribing information can be found at the link below:
Information regarding PULMOZYME’s side effects can be found at MedlinePlus